The Centers for Disease Control and Prevention (CDC) awarded a cooperative agreement to the Council of Medical Specialty Societies (CMSS) to improve vaccination among high-risk adults. This five-year quality improvement initiative is focused on increasing immunization rates for high-risk adults with chronic medical conditions.

CMSS has partnered with seven specialty societies to implement targeted immunization and quality improvement strategies and activities which will support increased vaccination of high-risk patients served by their members.

The American Thoracic Society is the world's leading medical society dedicated to accelerating the advancement of global respiratory health through multidisciplinary collaboration, education, and advocacy. Core activities of the Society’s more than 16,000 members are focused on leading scientific discoveries, advancing professional development, impacting global health, and transforming patient care. Key areas of member focus include developing clinical practice guidelines, hosting the annual International Conference, publishing four peer-reviewed journals, advocating for improved respiratory health globally, and developing an array of patient education and career development resources. To learn more about ATS's involvement within the Specialty Societies Advancing Adult Immunizations project, please click here.

The Specialty Societies Advancing Adult Immunization (SSAAI) program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award to the Council of Medical Specialty Societies (CMSS) totaling $42,175,407 with 100 percent funded by CDC/HHS. The contents are those of the authors and do not necessarily represent the official views of nor endorsement, by CDC/HHS or the U.S. Government.